CAS 52705-93-8

Ginsenoside Rd

Description:

Ginsenoside Rd is a triterpenoid saponin primarily found in ginseng, a plant renowned for its medicinal properties. It is one of the many ginsenosides, which are the active compounds believed to contribute to ginseng's health benefits. Ginsenoside Rd is characterized by its complex molecular structure, which includes a steroid-like backbone with multiple hydroxyl groups, contributing to its solubility and biological activity. This compound is known for its potential pharmacological effects, including anti-inflammatory, neuroprotective, and antioxidant properties. It has been studied for its ability to enhance cognitive function and support cardiovascular health. Ginsenoside Rd is typically extracted from ginseng roots and can be analyzed using various techniques such as high-performance liquid chromatography (HPLC). Its safety profile is generally considered favorable, although further research is necessary to fully understand its mechanisms of action and therapeutic potential. As with any bioactive compound, the effects can vary based on dosage, formulation, and individual health conditions.

Formula: C₄₈H₈₂O₁₉

InChI: InChI=1/C48H82O18/c1-21(2)15-22(3)17-48(8,66-43-40(60)37(57)34(54)28(19-50)62-43)24-11-13-47(7)23-9-10-30-45(4,5)31(12-14-46(30,6)25(23)16-26(52)32(24)47)64-44-41(38(58)35(55)29(20-51)63-44)65-42-39(59)36(56)33(53)27(18-49)61-42/h15,22-44,49-60H,9-14,16-20H2,1-8H3/t22?,23?,24-,25?,26-,27+,28+,29+,30?,31?,32+,33+,34+,35+,36-,37-,38-,39+,40+,41+,42-,43-,44-,46+,47+,48-/m0/s1

InChI key: InChIKey=RLDVZILFNVRJTL-IWFVLDDISA-N

SMILES: C[C@]12[C@@]([C@]3(C)[C@@](CC1)(C(C)(C)[C@@H](O[C@H]4[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@@H](CO)O4)CC3)[H])(C[C@@H](O)[C@]6([C@@]2(C)CC[C@@]6([C@@](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)(CCC=C(C)C)C)[H])[H])[H]

Synonyms:

• (3β,12β)-20-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-<smallcap>D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-glucopyranoside
• (8xi,9xi,12alpha,13alpha,14beta,17beta)-17-[(1S)-1-(beta-D-glucopyranosyloxy)-1,3,5-trimethylhex-4-en-1-yl]-12-hydroxy-4,4,10,14-tetramethylgonan-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
• 2-O-beta-D-Glucopyranosyl-(3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-beta-D-glucopyranoside
• 3-O-β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyl-(1→2)-β-<smallcap>D</smallcap>-glucopyranosyl-20-O-β-<smallcap>D</span>-glucopyranosyldammar-24-ene-3β,12β,20S-triol
• Chikusetsusaponin FK₇
• Dammarane, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
• Ginsenoside Rd1
• Gold Theragran P.E.
• Gypenoside VIII
• beta-D-Glucopyranoside, (3-beta,12-beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-
• β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,12β)-20-(β-<smallcap>D</smallcap>-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-<smallcap>D</span>-glucopyranosyl-
• Dammarane, β-D-glucopyranoside deriv.
• (3β,12β)-20-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
• Ginsenoside Rd
• β-D-Glucopyranoside, (3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-
• GINSENOSIDE Rd hplc
• beta-d-glucopyranoside,(3-beta,12-beta)-20-(beta-d-glucopyranosyloxy)-12-hydro
• xydammar-24-en-3-yl2-o-beta-d-glucopyranosyl-
• 3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-ene-12β-ol
• (20S)-3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-ene-12β-ol
• β-D-Glucopyranoside,(3β,12β)-20-(β-D-
• Ginsenoside Rd std.
• GINSENOSIDE RD WITH HPLC
• (20S)-3β-[[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyl]oxy]-20-(β-D-glucopyranosyloxy)dammaran-24-ene-12β-ol
• 20-(β-D-Glucopyranosyloxy)-12β-hydroxy-5α-dammar-24-ene-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
• GINSENOOSIDERD
• [20-(β-D-Glucopyranosyloxy)-12β-hydroxydammar-24-en-3β-yl]2-O-β-D-glucopyranosyl-β-D-glucopyranoside
• Ginsenoside Rd (CAS# 52705-93-87)

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd

Formula: C₄₈H₈₂O₁₈

Purity: ≥98%

Molecular weight: 947.15

Ref: 54-BUP07726

Ginsenoside Rd

CAS: 52705-93-8

Formula: C₄₈H₈₂O₁₈

Color and Shape: White To Off-White Solid

Molecular weight: 947.17

Ref: 4Z-G-157013

Ginsenoside Rd

CAS: 52705-93-8

Formula: C₄₈H₈₂O₁₈

Purity: ≥ 98.0%

Color and Shape: White to pale yellow powder

Molecular weight: 947.15

Ref: 7W-GC2429

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd analytical standard provided with w/w absolute assay, to be used for quantitative titration.

Formula: C₄₈H₈₂O₁₈

Purity: (HPLC) ≥98%

Color and Shape: Powder

Molecular weight: 947.18

Ref: 11-0102S

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd (Rd), a saponin isolated from the roots of panax notoginseng, Rd has immunological adjuvant activity, and elicits a Th1 and Th2 immune response by regulating production and gene expression of Th1 cytokines and Th2 cytokines.

Formula: C₄₈H₈₂O₁₈

Purity: 95%~99%

Color and Shape: White powder

Molecular weight: 947.166

Ref: BP-BP0661

Ginsenoside Rd (Standard)

CAS: 52705-93-8

Ginsenoside Rd (Standard) is a reference standard for research and analysis in studies involving Ginsenoside Rd. Ginsenoside Rd (Gypenoside VIII) may have properties that inhibit or prevent the growth of tumors.

Formula: C₄₈H₈₂O₁₈

Molecular weight: 947.1539

Ref: TM-TMSM-2692

Ginsenoside Rd

Controlled Product

CAS: 52705-93-8

Stability Hygroscopic
Applications Ginsenoside RD has been shown to attenuate tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after forebrain ischemia. This could be used to counter the risk of developing post-stroke dementia.
References Zhang, X. et al.: Neurochem. Res., 39, 1363 (2014); Zhu, D. et al.: J. Neurosci. Res., 92, 1217 (2014);

Formula: C₄₈H₈₂O₁₈

Color and Shape: Neat

Molecular weight: 947.15

Ref: TR-G387620

Ginsenoside Rd

CAS: 52705-93-8

(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Formula: C₄₈H₈₂O₁₈

Purity: 98%

Molecular weight: 947.15

Ref: IN-DG9356

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd (Gypenoside VIII) may have properties that inhibit or prevent the growth of tumors.

Formula: C₄₈H₈₂O₁₈

Purity: 99.13% - 99.92%

Color and Shape: White Solid

Molecular weight: 947.1539

Ref: TM-T2878

Ginsenoside Rd

CAS: 52705-93-8

Natural glycoside

Formula: C₄₈H₈₂O₁₈

Purity: ≥ 90.0 % (HPLC)

Color and Shape: Powder

Molecular weight: 947.17

Ref: 5G-89211

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd is a bioactive compound, classified as a saponin, which is derived from the roots of Panax ginseng. This ginsenoside is a dammarane-type triterpenoid saponin and is one of the major active components found in ginseng extracts. The mode of action of Ginsenoside Rd involves multiple biochemical pathways, including anti-inflammatory, antioxidant, and neuroprotective effects. It modulates signaling pathways such as MAPK and PI3K/Akt, resulting in diverse biological activities.

Formula: C₄₈H₈₂O₁₈

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 947.18 g/mol

Ref: 3D-OG09282

Ginsenoside Rd

CAS: 52705-93-8

Formula: C₄₈H₈₂O₁₈

Molecular weight: 947.2

Ref: BE-RMT16300

Ginsenoside Rd

CAS: 52705-93-8

Formula: C₄₈H₈₂O₁₈

Molecular weight: 947.2

Ref: BE-RMCG062013

Ginsenoside Rd

CAS: 52705-93-8

Formula: C₄₈H₈₂O₁₈

Purity: >98.0%(HPLC)

Color and Shape: White to Almost white powder to crystal

Molecular weight: 947.17

Ref: 3B-G0550

Ginsenoside Rd

CAS: 52705-93-8

Formula: C₄₈H₈₂O₁₈

Molecular weight: 947.2

Ref: ST-EA-CP-G62004